Exploring enzymes that break down hydrocarbons for environmental and health benefits
Investigation and application of hydrocarbon-degrading enzymes using cryo-electron microscopy and directed evolution
This study is looking at special enzymes that help break down harmful substances in our bodies and the environment, which could lead to new treatments for liver and heart diseases and better ways to clean up pollution.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-10912071 on NIH RePORTER |
What this research studies
This research investigates glycyl radical enzymes (GREs), which are crucial for breaking down hydrocarbons in environments like the human gut and polluted areas. By using advanced techniques such as cryo-electron microscopy and directed evolution, the study aims to characterize these enzymes, particularly X-succinate synthases (XSSs), which can activate hydrocarbons for degradation. This could lead to new methods for bioremediation and understanding their role in diseases affecting the liver and heart. Patients may benefit from insights into how these enzymes can be targeted for therapeutic purposes or environmental health.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals with liver or heart diseases, as well as those interested in environmental health.
Not a fit: Patients with conditions unrelated to liver or heart diseases, or those not affected by environmental pollutants, may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments for cardiac and hepatic diseases and improved methods for cleaning up environmental pollutants.
How similar studies have performed: Other research has shown promise in utilizing similar enzymatic approaches for bioremediation and health applications, indicating a potential for success in this area.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Andorfer, Mary Catherine — Michigan State University
- Study coordinator: Andorfer, Mary Catherine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.